Advance novel TB drug regimens

TB Alliance is focused on: 1. Improved TB therapeutic regimens that are developed, registered, and available to those who need them -- making a major impact on the global TB pandemic 2. Progress is made on the development of new compounds that offer promise to hit novel targets and achieve in vivo cure of TB in optimized combinations in 8-12 weeks and the best potential combinations are assessed for clinical regimen development.